ATS Medical (ATSI) Announces FDA Okay of the ATS Simulus Adjustable Annuloplasty Band
More News related to ATSI
- ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
- Piper Jaffray Upgrades ATS Medical (ATSI) to Overweight; Trims 2010 EPS Outlook
- After-Hours Movers 11/02: BDK, DDRX, ATSI, HLF, HTCH, SNCR, CAR Higher; TNS, HIMX, SVR, TXRH Lower
- ATS Medical (ATSI) Posts Q3 Loss of 1c, In-Line with Estimates
- ATS Medical Announces Third Quarter 2009 Results
More News related to ATSI
More News related to FDA
- After-Hours Movers 11/09: SGK, PCLN, SQNM Higher; MBI, SDTH, UTK, TOPS, CPST, BTN, FLR Lower
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Unusual 11 Mid-Day Movers 11/09: EONC, EWBC, REV, PRST Higher; GTN, CHNG, SRZ, CHDX Lower
- Notable Analyst Rating Changes: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
More News related to FDA
May 12, 2009 7:00 AM EDT
ATS Medical, Inc. (Nasdaq: ATSI) announced FDA clearance of the ATS Simulus Adjustable Annuloplasty Band.
The ATS Simulus Adjustable Annuloplasty Band is the next product in a portfolio of mitral valve repair products developed and commercialized through the Company's partnership with Genesee BioMedical.
Related Categories
FDA
Stocks Mentioned